Edition:
United Kingdom

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

4.45USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$4.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
150,105
52-wk High
$9.49
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.107
Mar '18 0.00 -0.122
FY 2017 Dec '17 0.00 -0.073
Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 2 -0.12 -0.11 -0.12 --
Quarter Ending Dec-18 2 -0.12 -0.11 -0.12 --
Year Ending Dec-18 2 -0.46 -0.45 -0.46 -0.79
Year Ending Dec-19 1 -1.06 -1.06 -1.06 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.69 32.76
P/E High - Last 5 Yrs. -- 300.66 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 2.59 0.93 0.89
Price to Sales (TTM) -- 114.99 5.75
Price to Book (MRQ) -- 15.52 5.00
Price to Tangible Book (MRQ) 14.70 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 11.19 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.56 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.51 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.96 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 31.23 -- --
EPS - 5 Yr. Growth Rate -- 39.85 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 2.66 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.36 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.69 10.65
Operating Margin (TTM) -- -759.79 4.32
Operating Margin - 5 Yr. Avg. -- -621.72 6.06
Pre-Tax Margin (TTM) -- -733.64 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.42 6.49
Net Profit Margin (TTM) -- -735.01 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.47 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,231,105 860,375,103
Net Income/Employee (TTM) -2,651,714 3,144,294 101,207,184
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -134.62 -0.16 11.13
Return on Assets - 5 Yr. Avg. -90.24 3.51 12.40
Return on Investment (TTM) -181.73 1.78 14.61
Return on Investment - 5 Yr. Avg. -102.11 2.56 16.13
Return on Equity (TTM) -1,032.02 3.28 16.33
Return on Equity - 5 Yr. Avg. -235.00 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.67%
# of Holders: 76
Total Shares Held: 5,591,599
3 Mo. Net Change: 691,182
# New Positions: 21
# Closed Positions: 11
# Increased Positions: 43
# Reduced Positions: 26
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.